Your browser is no longer supported. Please, upgrade your browser.
PetVivo Holdings, Inc.
Index- P/E- EPS (ttm)-0.41 Insider Own37.20% Shs Outstand8.75M Perf Week-10.32%
Market Cap27.19M Forward P/E- EPS next Y-0.85 Insider Trans0.62% Shs Float5.64M Perf Month-29.26%
Income-3.00M PEG- EPS next Q-0.15 Inst Own5.90% Short Float9.70% Perf Quarter0.00%
Sales0.01M P/S1824.36 EPS this Y-44.80% Inst Trans1.58% Short Ratio0.49 Perf Half Y-65.21%
Book/sh0.98 P/B2.84 EPS next Y-60.40% ROA-93.90% Target Price7.00 Perf Year-78.94%
Cash/sh- P/C- EPS next 5Y- ROE-188.50% 52W Range2.36 - 14.30 Perf YTD-26.26%
Dividend- P/FCF- EPS past 5Y22.80% ROI- 52W High-80.56% Beta1.74
Dividend %- Quick Ratio7.70 Sales past 5Y- Gross Margin- 52W Low17.80% ATR0.34
Employees2 Current Ratio7.80 Sales Q/Q3.90% Oper. Margin- RSI (14)35.68 Volatility10.84% 9.98%
OptionableNo Debt/Eq0.00 EPS Q/Q45.30% Profit Margin- Rel Volume0.16 Prev Close2.80
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.12M Price2.78
Recom2.00 SMA20-18.77% SMA50-22.87% SMA200-53.89% Volume185,112 Change-0.71%
Jan-19-22 07:00AM  
Jan-17-22 10:30AM  
Jan-10-22 07:45AM  
Jan-05-22 07:30AM  
Jan-04-22 08:00AM  
Dec-13-21 08:00AM  
Dec-06-21 10:30AM  
Dec-03-21 09:00AM  
Nov-30-21 11:00AM  
Nov-29-21 08:00AM  
Nov-15-21 05:10PM  
Nov-11-21 04:30PM  
Nov-01-21 01:45PM  
Oct-29-21 01:34PM  
Oct-27-21 10:27AM  
Oct-25-21 11:01AM  
Oct-22-21 01:23PM  
Oct-15-21 01:30PM  
Oct-14-21 09:15AM  
Oct-07-21 09:46AM  
Oct-05-21 08:00AM  
Sep-28-21 07:00AM  
Sep-27-21 09:15AM  
Sep-24-21 03:45PM  
Sep-20-21 02:17PM  
Sep-10-21 09:00AM  
Sep-09-21 10:15AM  
Sep-08-21 08:00AM  
Sep-06-21 10:45AM  
Sep-02-21 08:00AM  
Aug-30-21 10:42AM  
Aug-27-21 12:15PM  
Aug-25-21 08:00AM  
Aug-23-21 11:00AM  
Aug-20-21 12:16PM  
Aug-19-21 10:35AM  
Aug-17-21 07:00AM  
Aug-16-21 11:37AM  
Aug-13-21 02:47PM  
Aug-10-21 08:32PM  
Jul-07-21 10:13AM  
Apr-28-21 07:00AM  
Apr-16-21 07:30AM  
Dec-07-20 07:00AM  
Nov-12-20 08:00AM  
Oct-20-20 07:00AM  
Oct-05-20 08:00AM  
Sep-10-20 08:00AM  
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martin James RudolphDirectorOct 05Buy2.461,6003,93786,684Oct 06 05:06 PM
Martin James RudolphDirectorSep 14Buy2.961,2003,55285,084Sep 15 02:31 PM
Martin James RudolphDirectorSep 13Buy3.247,00022,66583,884Sep 14 12:04 PM
Rudelius Robert JamesDirectorSep 02Option Exercise1.271,5942,031181,664Sep 03 02:41 PM
Folkes Robert J.Chief Financial OfficerSep 02Buy3.9110,00039,12413,000Sep 07 12:53 PM
Martin James RudolphDirectorAug 25Buy2.672,0005,33676,884Aug 26 02:58 PM
Johnson Scott MitchellDirectorAug 13Buy4.504,00018,00014,575Nov 02 07:28 PM
Johnson Scott MitchellDirectorMay 10Sale8.541,22110,42610,575Nov 02 07:28 PM
Johnson Scott MitchellDirectorMay 05Sale7.752,11516,39111,796Nov 02 07:28 PM
Johnson Scott MitchellDirectorMay 04Sale8.781901,66813,911Nov 02 07:28 PM